Balanced sn-2 myristate-containing edible oil
US8114461B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 25, 2008 |
| Grant date | Feb 14, 2012 |
| Priority date | — |
| Expiry date | Aug 25, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23L33/12
- WIPO fieldFood chemistry
- WIPO sectorChemistry
Abstract
A nutritional fat or oil-based composition for increasing HDL cholesterol, decreasing LDL cholesterol and decreasing the LDL/HDL cholesterol ratio in human plasma is described. The composition typically includes at least 1% by weight myristic acid esterified at the sn-2 position in triglyceride molecules, includes between 10% and 40% by weight linoleic acid, and further includes between 30% and 65% by weight oleic acid and between 15% and 40% by weight total saturated fatty acids. The ratio of sn-2 myristic acid to sn-2 palmitic acid is typically greater than 1:1 and the sum of weight percentages for saturated, monounsaturated and polyunsaturated fatty acids equals 100%. In desirable cases, the composition is substantially cholesterol-free.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.